Avenue Therapeutics

Avenue Therapeutics Overview

Founded 2015
Founded
Status Public
Employees 4
Employees
Stock Symbol ATXI
Stock Symbol
Share Price $10.47 (As of Thursday Closing)

Avenue Therapeutics General Information

Description

Avenue Therapeutics Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl, or IV Tramadol, for the management of postoperative pain.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 2 Gansevoort Street
  • 9th Floor
  • New York, NY 10014
  • United States
+1 (781) 000-0000

Avenue Therapeutics Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Avenue Therapeutics Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.47 $10.50 $4.96 - $11.83 $175M 16.7M 63.4K -$0.98

Avenue Therapeutics Financials Summary

In Thousands,
USD
TTM 31-Mar-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 140,399 146,208 52,802 11,110
Revenue 0 0 0 0
EBITDA (21,641) (11,971)
Net Income (15,881) (25,908) (21,548) (12,258)
Total Assets 6,696 8,915 4,525 22,170
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Avenue Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Avenue Therapeutics‘s full profile, request access.

Request a free trial

Avenue Therapeutics Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Omeros Formerly VC-backed Seattle, WA 000 00000 00000000 00000
00000000 000000000 Formerly VC-backed South San Francisco, CA 00 00000 000000 - 000 00000
000000000 00000000 Formerly VC-backed Tarrytown, NY 0000 00000 00000000000 00000
0000000 00000000 Formerly VC-backed Bothell, WA 0000 00000 000000 - 000 00000
0000000 0000000000 Venture Capital-Backed San Diego, CA 0 0000 00000000000 0000

Avenue Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Lucy Lu MD Chief Executive Officer & Board Member
Joseph Vazzano Chief Financial Officer, Finance
Lindsay Rosenwald MD Executive Chairman & Board Member
Scott Reines MD Chief Medical Officer

2 Former Executives

Avenue Therapeutics Board Members (6)

To view Avenue Therapeutics‘s full board member team, request access »
Name Representing Role Since
0000000 00000 00 Avenue Therapeutics Board Member 000 0000
0000000 000000000 00 Avenue Therapeutics Executive Chairman & Board Member 000 0000
0000 00 00 Avenue Therapeutics Chief Executive Officer & Board Member 000 0000
0000 0000000000 Avenue Therapeutics Board Member 000 0000

2 Former Board Members

Avenue Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Avenue Therapeutics‘s full profile, request access.

Request a free trial

Ready to get started?

Request a free trial